• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsHanmi Pharm
    Picture of Hanmi Pharm logo

    128940 — Hanmi Pharm Share News

    KR₩465,5000.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    • Market Cap
      KR₩6tn
    • Enterprise Value
      KR₩6tn
    • Revenue
      KR₩2tn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • 128940 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    128940 Dividends
    • S.Korea's biotech, pharma stocks rise after revised accounting rule guideline

      20/09/2018 04:10
    • S.Korea stocks, won drop on concerns over Trump's trade threat

      31/08/2018 03:05
    • S.Korea's pharma shrs jump on plans to revise supervisory standards on accounting rules

      31/08/2018 02:16
    • S.Korea's biopharmaceutical shares fall on dimmer outlook

      13/08/2018 04:50
    • S.Korea's Hanmi Pharm soars, diabetes drug enters phase 2 clinical trial

      10/04/2018 04:00
    • Brief: Hanmi Pharm to buy facilities for 113.3 bln won

      19/01/2017 07:54
    • Brief: Hanmi Science unit Hanmi Pharm says issuance of 728,341 bonus shares

      03/01/2017 05:36
    • Sanofi sees strong profit growth from 2018, to cut costs (updated)

      06/11/2015 07:53
    • Sanofi sees strong profit growth from 2018, to cut costs

      06/11/2015 06:00
    • Sanofi, Hanmi seal diabetes licence deal for up to $4.2 bln (updated)

      05/11/2015 11:32
    • Sanofi, Hanmi seal diabetes licence deal for up to $4.2 bln (updated)

      05/11/2015 09:16
    • AstraZeneca says competitor to blockbuster Nexium launched in U.S.

      17/12/2013 19:19
    • U.S. court temporarily blocks a competitor to AstraZeneca's Nexium

      14/09/2013 01:11
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.